Aflibercept +/- LV5FU2 in First Line of Non-resectalbe Metastatic Colorectal Cancers

NCT02384759 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

117

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: aflibercept
DRUG: LV5FU2

Sponsor

Federation Francophone de Cancerologie Digestive